Joellen Weaver

Technical Director
Institute for Translational Medicine and Therapeutics, Perelman School of Medicine
Philadelphia, Pennsylvania, United States

Presentation(s):

• PB0776 - Characterization of the effects of hydroxyurea and crizanlizumab on plasma immunothrombosis biomarkers in patients with sickle cell disease

  Monday, June 26, 2023
  18:30 – 19:30 ET

• PB1505 - C-reactive protein across the menstrual cycle in females with sickle cell disease

  Tuesday, June 27, 2023
  18:30 – 19:30 ET